300 related articles for article (PubMed ID: 18420712)
1. Interrelation of inflammation and APP in sIBM: IL-1 beta induces accumulation of beta-amyloid in skeletal muscle.
Schmidt J; Barthel K; Wrede A; Salajegheh M; Bähr M; Dalakas MC
Brain; 2008 May; 131(Pt 5):1228-40. PubMed ID: 18420712
[TBL] [Abstract][Full Text] [Related]
2. Proinflammatory cell stress in sporadic inclusion body myositis muscle: overexpression of alphaB-crystallin is associated with amyloid precursor protein and accumulation of beta-amyloid.
Muth IE; Barthel K; Bähr M; Dalakas MC; Schmidt J
J Neurol Neurosurg Psychiatry; 2009 Dec; 80(12):1344-9. PubMed ID: 19470495
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide stress in sporadic inclusion body myositis muscle fibres: inhibition of inducible nitric oxide synthase prevents interleukin-1β-induced accumulation of β-amyloid and cell death.
Schmidt J; Barthel K; Zschüntzsch J; Muth IE; Swindle EJ; Hombach A; Sehmisch S; Wrede A; Lühder F; Gold R; Dalakas MC
Brain; 2012 Apr; 135(Pt 4):1102-14. PubMed ID: 22436237
[TBL] [Abstract][Full Text] [Related]
4. Comment on 'Interrelation of inflammation and APP in sIBM: IL-1beta induces accumulation of beta-amyloid in skeletal muscle'.
Greenberg SA
Brain; 2009 Apr; 132(Pt 4):e106; author reply e107. PubMed ID: 18669503
[No Abstract] [Full Text] [Related]
5. Provision of an explanation for the inefficacy of immunotherapy in sporadic inclusion body myositis: quantitative assessment of inflammation and β-amyloid in the muscle.
Zschüntzsch J; Voss J; Creus K; Sehmisch S; Raju R; Dalakas MC; Schmidt J
Arthritis Rheum; 2012 Dec; 64(12):4094-103. PubMed ID: 22941914
[TBL] [Abstract][Full Text] [Related]
6. Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies.
Choi YC; Dalakas MC
Neurology; 2000 Jan; 54(1):65-71. PubMed ID: 10636127
[TBL] [Abstract][Full Text] [Related]
7. Beta-amyloid is a substrate of autophagy in sporadic inclusion body myositis.
Lünemann JD; Schmidt J; Schmid D; Barthel K; Wrede A; Dalakas MC; Münz C
Ann Neurol; 2007 May; 61(5):476-83. PubMed ID: 17469125
[TBL] [Abstract][Full Text] [Related]
8. Cell stress molecules in the skeletal muscle of GNE myopathy.
Fischer C; Kleinschnitz K; Wrede A; Muth I; Kruse N; Nishino I; Schmidt J
BMC Neurol; 2013 Mar; 13():24. PubMed ID: 23496965
[TBL] [Abstract][Full Text] [Related]
9. Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity.
Schmidt J; Rakocevic G; Raju R; Dalakas MC
Brain; 2004 May; 127(Pt 5):1182-90. PubMed ID: 15047591
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes.
Authier FJ; Mhiri C; Chazaud B; Christov C; Cherin P; Barlovatz-Meimon G; Gherardi RK
Neuropathol Appl Neurobiol; 1997 Apr; 23(2):132-40. PubMed ID: 9160898
[TBL] [Abstract][Full Text] [Related]
11. Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies.
De Paepe B; De Keyzer K; Martin JJ; De Bleecker JL
Acta Neuropathol; 2005 Jun; 109(6):576-82. PubMed ID: 15937690
[TBL] [Abstract][Full Text] [Related]
12. Human β-defensin-3 correlates with muscle fibre degeneration in idiopathic inflammatory myopathies.
Güttsches AK; Jacobsen F; Theiss C; Rittig A; Rehimi R; Kley RA; Vorgerd M; Steinstraesser L
Innate Immun; 2014 Jan; 20(1):49-60. PubMed ID: 23608825
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-β signaling is upregulated in sporadic inclusion body myositis.
Noda S; Koike H; Maeshima S; Nakanishi H; Iijima M; Matsuo K; Kimura S; Katsuno M; Sobue G
Muscle Nerve; 2017 May; 55(5):741-747. PubMed ID: 27623743
[TBL] [Abstract][Full Text] [Related]
14. HMGB1 and RAGE in skeletal muscle inflammation: Implications for protein accumulation in inclusion body myositis.
Muth IE; Zschüntzsch J; Kleinschnitz K; Wrede A; Gerhardt E; Balcarek P; Schreiber-Katz O; Zierz S; Dalakas MC; Voll RE; Schmidt J
Exp Neurol; 2015 Sep; 271():189-97. PubMed ID: 26048613
[TBL] [Abstract][Full Text] [Related]
15. Macroautophagy as a pathomechanism in sporadic inclusion body myositis.
Lünemann JD; Schmidt J; Dalakas MC; Münz C
Autophagy; 2007; 3(4):384-6. PubMed ID: 17438365
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor I in inclusion-body myositis and human muscle cultures.
Broccolini A; Ricci E; Pescatori M; Papacci M; Gliubizzi C; D'Amico A; Servidei S; Tonali P; Mirabella M
J Neuropathol Exp Neurol; 2004 Jun; 63(6):650-9. PubMed ID: 15217093
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes.
Raju R; Dalakas MC
Brain; 2005 Aug; 128(Pt 8):1887-96. PubMed ID: 15857930
[TBL] [Abstract][Full Text] [Related]
18. mTOR is expressed in polymyositis but not in sporadic inclusion body myositis.
Panaite PA; Stalder AK; Ipsen S; Kuntzer T; Steck AJ
Clin Neuropathol; 2015; 34(6):371-3. PubMed ID: 26104108
[No Abstract] [Full Text] [Related]
19. Gain and loss of extracellular molecules in sporadic inclusion body myositis and polymyositis--a proteomics-based study.
Doppler K; Lindner A; Schütz W; Schütz M; Bornemann A
Brain Pathol; 2012 Jan; 22(1):32-40. PubMed ID: 21672074
[TBL] [Abstract][Full Text] [Related]
20. T-Cell-Mediated Inflammatory Myopathies in HIV-Positive Individuals: A Histologic Study of 19 Cases.
Hiniker A; Daniels BH; Margeta M
J Neuropathol Exp Neurol; 2016 Mar; 75(3):239-45. PubMed ID: 26843609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
